Botanical species · safety record

Drimys winteri

The EFSA Compendium of Botanicals holds 6 constituent measurements for Drimys winteri. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Drimys winteri J.R.Forst. & G.Forst.

6Constituent measurements
0Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Drimenin1
  • Eugenol1
  • Myristicin1
  • Safrole1
  • Sesquiterpene lactones1
  • Tannic acid1

Plant parts

  • Leaves3
  • Bark2
  • Stem1
  • stalk1

Preparations

  • Solvent extraction4
  • Essential oil2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Sesquiterpene lactonesBarkSolvent extractionResolve DOI
DrimeninBarkSolvent extractionChromatographic testsNo resolvable identifier
EugenolLeavesEssential oil1.09 PercentGC-MSNo resolvable identifier
MyristicinLeavesEssential oil3.66 PercentGC-MSNo resolvable identifier
SafroleLeavesSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Tannic acidStem / stalkSolvent extractionNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Lemesle, Robert. A complex tannin-resin-protein substance in the bark of Drimys winteri. Compt. rend., 1942, p. 237-238.
  2. Sierra, Jorge R., Lopez, Jose T., Cortes, Manuel J. (-)-3beta-Acetoxydrimenin from the leaves of Drimys winteri. Phytochemistry, 1986, p. 253-254.
  3. Paz Robles, Cristian., Mercado, Dario., Suarez, Sebastian., Baggio, Ricardo. Two drimane lactones, valdiviolide and 11-epivaldiviolide, in the form of a 1:1 cocrystal obtained from Drimys winteri extracts. ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2014, vol. 70, p. 1112-+. DOI
  4. Verdeguer, Mercedes., Garcia-Rellan, David., Boira, Herminio., Perez, Eduardo., Gandolfo, Sandra., Blazquez, Maria Amparo. Herbicidal activity of Peumus boldus and Drimys winterii essential oils from Chile. Molecules, 2011, p. 403-411.
  5. Brito, Ivan., Cardenas, Alejandro., Zarraga, Miguel., Paz, Cristian., Perez, Claudia., Lopez-Rodriguez, Matias. X-RAY CRYSTALLOGRAPHIC STRUCTURAL STUDY ON A CINNAMOLIDE-CLASS SESQUITERPENE LACTONE FROM DRIMYS WINTERI FORST. VAR. CHILENSIS. JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2008, vol. 53, no. 4, p. 1732-1733.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue